Capital Group Private Client Services, Inc.
Source: SEC Form 13F · as of Mar 2026Capital Group Private Client Services, Inc. holds 12 biotech & pharma companies tracked by BioSniper, totaling $164.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$164.6M
| Company | Shares | Value |
|---|---|---|
| AZNASTRAZENECA PLC | 241,824 | $47.1M |
| PMPhilip Morris International Inc | 166,167 | $27.5M |
| AMGNAMGEN INC | 53,491 | $18.8M |
| ABTABBOTT LABORATORIES | 146,523 | $15.0M |
| LLYELI LILLY & Co | 15,568 | $14.3M |
| ABBVAbbVie Inc. | 57,646 | $12.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 32,164 | $8.7M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 19,226 | $8.6M |
| ONCBeOne Medicines Ltd. | 28,656 | $8.5M |
| QGENQIAGEN N.V. | 71,378 | $2.9M |
| NVONovo Nordisk A/S | 11,956 | $439K |
| JNJJOHNSON & JOHNSON | 1,003 | $245K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.